Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-504-3 | CAS number: 8060-28-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 1 (reliable without restriction)
- Justification for type of information:
- This study is taken from a recently-published scientific article by S. Suzuki et al. on "Genetic, acute and subchronic toxicity studies of matured hop extract produced by extraction from heat-treated hops", published in the Journal of Toxicological Sciences (2018) vol. 43, no. 7, pp. 473-484, available freely as full text in the public domain. Matured hop extract contains oxidised alpha and beta acids. This substance is therefore of direct relevance to hop extract, and to alpha acids, iso-alpha acids, and beta acids, as the oxidised alpha and beta acids are common degradation products of hop alpha and beta acids. This article is useful in that it reports a number of toxicological studies, and the in vivo tests on chromosome aberration are reported in this end-point to add as weight of evidence for the lack of genotoxicity expected for hop extract and its constituents.
Data source
Reference
- Reference Type:
- publication
- Title:
- Genetic, acute and subchronic toxicity studies of matured hop extract produced by extraction from heat-treated hops
- Author:
- Shigeo Suzuki, Yumie Morimoto-Kobayashi, Chika Takahashi, Yoshimasa Taniguchi, Mikio Katayama
- Year:
- 2 018
- Bibliographic source:
- https://www.jstage.jst.go.jp/article/jts/43/7/43_473/_html/-char/en
- Report date:
- 2018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: In accordance with a previous protocol, viz. Hayashi, M., Sofuni, T. and Ishidate, M. Jr. (1983): An application of Acridine Orange fluorescent staining to the micronucleus test. Mutat. Res., 120, 241-247.
- GLP compliance:
- not specified
- Type of assay:
- mammalian germ cell cytogenetic assay
Test material
- Reference substance name:
- Hop, Humulus lupulus, ext.
- EC Number:
- 232-504-3
- EC Name:
- Hop, Humulus lupulus, ext.
- Cas Number:
- 8060-28-4
- Molecular formula:
- No simple molecular formula for UVCB
- IUPAC Name:
- Hop, Humulus lupulus, ext.
- Test material form:
- liquid: viscous
- Remarks:
- Depending on the extraction conditions and on the hop variety, the colour of the extract can vary from yellow to dark green. It is a semi-fluid paste at room temperature. The product becomes more fluid when heated.
Constituent 1
- Specific details on test material used for the study:
- An aqueous extract of a heat-treated hop extract, designed for production and extraction of oxidised alpha and beta acids.
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Eight-week-old male rats. Body weight was between 289 - 310 g.
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- Sterlized water
- Details on exposure:
- High dose group: 2,000 mg/kg bw/day; middle dose group: 1,000 mg/kg bw/day; low dose group: 500 mg/kg bw/day. Once daily for 2 days.
- Duration of treatment / exposure:
- 2 days
- Frequency of treatment:
- Once daily
- Post exposure period:
- 24 h
Doses / concentrationsopen allclose all
- Dose / conc.:
- 2 000 mg/kg bw/day
- Remarks:
- High dose group
- Dose / conc.:
- 1 000 mg/kg bw/day
- Remarks:
- Middle dose group
- Dose / conc.:
- 500 mg/kg bw/day
- Remarks:
- Low dose group
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- MMC. This was dissolved in sterilized water and it was injected intraperitoneally at 2 mg/kg bw. One dose only.
Examinations
- Tissues and cell types examined:
- Bone marrow cell smears for erythrocytes.
- Details of tissue and slide preparation:
- Notes from journal: "Bone marrow cell smears were prepared and stained with acridine orange. Numbers of polychromatic erythrocytes (PCEs) per 200 erythrocytes, and micronucleated polychromatic erythrocytes (MNPCEs) per 2,000 PCEs were counted."
- Evaluation criteria:
- Notes from journal: "Numbers of polychromatic erythrocytes (PCEs) per 200 erythrocytes, and micronucleated polychromatic erythrocytes (MNPCEs) per 2,000 PCEs were counted."
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- These results are part of a larger study reported in the article. Results in brief:
• Ames test – negative, up to 5,000 ug per plate, with and without metabolic activation
• In vitro chromosomal aberration test – positive at 3,330 and 5,000 ug per plate without metabolic activation (i.e. elevated structural aberration above negative control) but no increase in polyploid cells
• In vivo micronucleus test in rat bone marrow – no clastogenic potential at max dose of 2,000 mg/kg bw/day, i.e. negative
• Acute toxicity – No noticeable toxic signs at 2,000 mg/kg bw
• 90 days study – NOAEL considered to be over 3,484 mg/kg bw/day for male and 4,022 mg/kg bw/day for female rats.
Authors’ conclusion is that although the structural chromosomal aberration was positive in high dose group for the in vitro test, Ames test and in vivo micronucleus test suggests that the matured hop extract has no potential for mutagenicity and genotoxicity under in vivo conditions.
Further consideration of results noted that cytotoxicity was observed in the in vitro test.If the toxicity mechanism was to slow cell division or similar, it could look like a chromosome aberration. The in vivo test indicates lack of genotoxicity at appropriate doses. The authors' comment was as follows: "From the results mentioned above, it is judged that MHE does not have clastogenic potential in rats at the maximum dose, which is recommended by OECD guidelines (OECD, 1997)."
Applicant's summary and conclusion
- Conclusions:
- The studies reported in this journal article add weight of evidence to the lack of toxicity of hop extract, in particular for substances derived from hop alpha and beta acids.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
